Melatonin and the metabolic syndrome : physiopathologic and therapeutical implications
Abstract: Metabolic syndrome (MS) patients exhibit sleep/wake disturbances and other circadian abnormalities and these may be associated with more rapid weight increase and development of diabetes and atherosclerotic disease. On this basis, the successful management of MS may require an ideal drug t...
Guardado en:
| Autores principales: | Cardinali, Daniel Pedro, Cano Barquilla, Pilar, Jiménez Ortega, Vanesa, Esquifino, Ana I. |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Inglés Inglés |
| Publicado: |
Karger Publishers
2019
|
| Materias: | |
| Acceso en línea: | https://repositorio.uca.edu.ar/handle/123456789/1619 |
| Aporte de: |
Ejemplares similares
-
Melatonin, mitochondria, and the metabolic syndrome
por: Cardinali, Daniel Pedro, et al.
Publicado: (2019) -
Cytoprotection by melatonin: The metabolic syndrome as an example
por: Cardinali, Daniel Pedro, et al.
Publicado: (2022) -
Chronophysiology of melatonin : therapeutical implications
por: Cardinali, Daniel Pedro, et al.
Publicado: (2019) -
Some implications of melatonin use in chronopharmacology of insomnia
por: Golombek, Diego A., et al.
Publicado: (2019) -
Melatonin and Benzodiazepine / Z Drug Abuse
por: Cardinali, Daniel Pedro, et al.
Publicado: (2020)